Literature DB >> 30373382

A next generation probiotic, Akkermansia muciniphila.

Qixiao Zhai1,2,3, Saisai Feng1,2, Narbad Arjan3,4, Wei Chen1,2,5,6,7.   

Abstract

Akkermansia muciniphila, a symbiotic bacterium of the mucus layer, can utilize mucin as its sole carbon, nitrogen, and energy source. As an abundant resident in the intestinal tract of humans and animals, the probiotic effects of A. muciniphila including metabolic modulation, immune regulation and gut health protection, have been widely investigated. Various diseases such as metabolic syndromes and auto-immnue diseases have been reported to be associated with the disturbance of the abundance of A. muciniphila. In this review, we describe the biological characterization of A. muciniphia, the factors that influence its colonization of the intestinal tract; and discuss the current state of our knowledge on its role in host health and disease.

Entities:  

Keywords:  Akkermansia muciniphila; diet; host health and disease; mucin

Mesh:

Substances:

Year:  2018        PMID: 30373382     DOI: 10.1080/10408398.2018.1517725

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  61 in total

Review 1.  Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications.

Authors:  Lili Zhang; Jinjin Chu; Wenhao Hao; Jiaojiao Zhang; Haibo Li; Chunjuan Yang; Jinghan Yang; Xiaohua Chen; Honggang Wang
Journal:  Mediators Inflamm       Date:  2021-08-17       Impact factor: 4.711

2.  The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.

Authors:  Zi-Yang Yi; Lin Chen; Yan Wang; Dan He; Di Zhao; Shui-Han Zhang; Rong Yu; Jian-Hua Huang
Journal:  Acta Diabetol       Date:  2022-07-20       Impact factor: 4.087

3.  Probiotic Lactobacilli Administration Induces Changes in the Fecal Microbiota of Preweaned Dairy Calves.

Authors:  Sofía Fernández-Ciganda; Martín Fraga; Pablo Zunino
Journal:  Probiotics Antimicrob Proteins       Date:  2021-08-14       Impact factor: 5.265

4.  Arabinoxylan and Pectin Metabolism in Crohn's Disease Microbiota: An In Silico Study.

Authors:  Carlos Sabater; Inés Calvete-Torre; Lorena Ruiz; Abelardo Margolles
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

5.  Lactiplantibacillus plantarum 0111 Protects Against Influenza Virus by Modulating Intestinal Microbial-Mediated Immune Responses.

Authors:  Jun-Hong Xing; Chun-Wei Shi; Ming-Jie Sun; Wei Gu; Rong-Rong Zhang; Hong-Liang Chen; Ying Li; Dan Wang; JunYi Li; Tian-Ming Niu; Qun-Tao Huang; Jia-Hao Qian; Hai Bin Huang; Yan-Long Jiang; Jian-Zhong Wang; Xin Cao; Nan Wang; Yan Zeng; Gui-Lian Yang; Wen Tao Yang; Chun-Feng Wang
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

Review 6.  Intestinal Flora: A Potential New Regulator of Cardiovascular Disease.

Authors:  Yifei Zou; Xianjing Song; Ning Liu; Wei Sun; Bin Liu
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

7.  Akkermansia muciniphila Alters Gut Microbiota and Immune System to Improve Cardiovascular Diseases in Murine Model.

Authors:  Xin He; Yang Bai; Haiyang Zhou; Kemin Wu
Journal:  Front Microbiol       Date:  2022-06-14       Impact factor: 6.064

Review 8.  Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis.

Authors:  Roshan Kumar; Utkarsh Sood; Vipin Gupta; Mona Singh; Joy Scaria; Rup Lal
Journal:  Indian J Microbiol       Date:  2019-05-25       Impact factor: 2.461

9.  Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study.

Authors:  Fang Ye; Xinying Gao; Zhiyi Wang; Shuman Cao; Guangcai Liang; Danni He; Zhitang Lv; Liming Wang; Pengfei Xu; Qi Zhang
Journal:  Synth Syst Biotechnol       Date:  2021-05-21

Review 10.  Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.

Authors:  Shengjie Yang; Dan Li; Zongliang Yu; Yujuan Li; Min Wu
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.